We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Algorithm Uses Key Signatures to Predict Onset of AD

By MedImaging International staff writers
Posted on 15 Oct 2018
Print article
A team of researchers has designed an artificial intelligence (AI) algorithm that learns signatures from magnetic resonance imaging (MRI), genetics, and clinical data to accurately predict cognitive decline leading to Alzheimer’s disease. The algorithm can help predict whether an individual’s cognitive faculties are likely to deteriorate towards Alzheimer’s in the next five years.

The researchers trained the algorithm by using data of more than 800 people ranging from normal healthy seniors to those experiencing mild cognitive impairment, and Alzheimer’s disease patients. They replicated their results within the study on an independently collected sample from the Australian Imaging and Biomarkers Lifestyle Study of Ageing. Using more data, the scientists will now be able to better identify those in the population at greatest risk for cognitive decline leading to Alzheimer’s.

“At the moment, there are limited ways to treat Alzheimer’s and the best evidence we have is for prevention. Our AI methodology could have significant implications as a ‘doctor’s assistant’ that would help stream people onto the right pathway for treatment. For example, one could even initiate lifestyle changes that may delay the beginning stages of Alzheimer’s or even prevent it altogether,” said Dr. Mallar Chakravarty, a computational neuroscientist at the Douglas Mental Health University Institute and Assistant Professor in McGill University’s Department of Psychiatry. “We are currently working on testing the accuracy of predictions using new data. It will help us to refine predictions and determine if we can predict even farther into the future.”

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Wireless Handheld Ultrasound System
TE Air
New
CT Phantom
CIRS Model 610 AAPM CT Performance Phantom
New
Mobile Digital C-arm X-Ray System
HHMC-200D

Print article
Radcal

Channels

MRI

view channel
Image: Diamond dust offers a potential alternative to the widely used contrast agent gadolinium in MRI (Photo courtesy of Max Planck Institute)

Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans

Gadolinium, a heavy metal used for over three decades as a contrast agent in medical imaging, enhances the clarity of MRI scans by highlighting affected areas. Despite its utility, gadolinium not only... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.